{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T17:32:53.812509+00:00","published_at":"2026-10-17T04:45:33.016234+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:4w92hgamjcgm","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:harp-dhaliwal","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:1464f89061053a45763a46d1f6ed741f4704d833be9c658fc7c08b99db5a5b56"],"summary":"Harp Dhaliwal executive of Vaxcyte, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1y5jbao1ex95m0","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-23","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:jim-wassil","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:21"],"evidence_ids":["alpha:projection-evidence:document:ca1aa6cadd13b94924dff4a32ddc105bea93609fa6794b1192f72a5fc3049744"],"summary":"Jim Wassil executive of Vaxcyte, Inc., effective 2026-04-23.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1tal4m2kj1uig","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:olivier-brandicourt","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Olivier Brandicourt seat on Vaxcyte, Inc., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1v36baor0xc8c","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:john-furey","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"John Furey seat on Vaxcyte, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1djfe1y14dvy1o","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2024-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:john-furey","alpha:committee:vaxcyte-inc:compensation"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_record:29"],"evidence_ids":["alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc"],"summary":"John Furey member of Compensation, effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:sew54o1047ozs","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:jacks-lee","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Jacks Lee seat on Vaxcyte, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jjjzr7bgdba1","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:annie-drapeau","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Annie Drapeau seat on Vaxcyte, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:13vvioq14id60i","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:carlos-paya-m-d-ph-d","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Carlos Paya, M.D., Ph.D. seat on Vaxcyte, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:lim4jvtkze3z","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:teri-loxam","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Teri Loxam seat on Vaxcyte, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:m05ecjpr56lz","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:vaxcyte-inc:audit-chair","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Audit · Chair committee of Vaxcyte, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:6q4rrvtmjhfn","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:teri-loxam","alpha:committee:vaxcyte-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Teri Loxam member of Audit · Chair, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:61s0hrewvri9","event_type":"COMMITTEE_CREATED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:vaxcyte-inc:compensation-chair-nominating-and-governance","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Compensation · Chair; Nominating and Governance committee of Vaxcyte, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:yt41t4mqtuaq","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:annie-drapeau","alpha:committee:vaxcyte-inc:compensation-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Annie Drapeau member of Compensation · Chair; Nominating and Governance, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1p3h2oe113xuru","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:halley-gilbert","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Halley Gilbert seat on Vaxcyte, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:jn1b1m1rws7xm","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:vaxcyte-inc:audit-nominating-and-governance-chair","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Audit; Nominating and Governance · Chair committee of Vaxcyte, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1sa6ctiorun0c","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:halley-gilbert","alpha:committee:vaxcyte-inc:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Halley Gilbert member of Audit; Nominating and Governance · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:kqnc2wrmtkfq","event_type":"DIRECTOR_APPOINTED","effective_at":"2013-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:grant-e-pickering-2","alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2"],"caused_claim_ids":["alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469"],"summary":"Grant E. Pickering seat on Vaxcyte, Inc., effective 2013-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:7","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:annie-drapeau","object_label":"Annie Drapeau","object_source_name_forms":[],"value":"Annie Drapeau: Director, Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:annie-drapeau","name":"Annie Drapeau"},"title":"Director","role_category":"director","committee":"Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Vaxcyte Inc DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-29T06:40:01.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:8","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:carlos-paya-m-d-ph-d","object_label":"Carlos Paya, M.D., Ph.D.","object_source_name_forms":[],"value":"Carlos Paya, M.D., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:carlos-paya-m-d-ph-d","name":"Carlos Paya, M.D., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Vaxcyte Inc DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-29T06:40:01.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:9","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:grant-e-pickering-2","object_label":"Grant E. Pickering","object_source_name_forms":[],"value":"Grant E. Pickering: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:grant-e-pickering-2","name":"Grant E. Pickering"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2013-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2013-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Vaxcyte Inc DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-29T06:40:01.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2013-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:10","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:halley-gilbert","object_label":"Halley Gilbert","object_source_name_forms":[],"value":"Halley Gilbert: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:halley-gilbert","name":"Halley Gilbert"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Vaxcyte Inc DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-29T06:40:01.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:11","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jacks-lee","object_label":"Jacks Lee","object_source_name_forms":[],"value":"Jacks Lee: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jacks-lee","name":"Jacks Lee"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Vaxcyte Inc DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-29T06:40:01.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:12","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-furey","object_label":"John Furey","object_source_name_forms":[],"value":"John Furey: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-furey","name":"John Furey"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Vaxcyte Inc DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-29T06:40:01.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:13","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:olivier-brandicourt","object_label":"Olivier Brandicourt","object_source_name_forms":[],"value":"Olivier Brandicourt: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:olivier-brandicourt","name":"Olivier Brandicourt"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Vaxcyte Inc DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-29T06:40:01.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:14","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:teri-loxam","object_label":"Teri Loxam","object_source_name_forms":[],"value":"Teri Loxam: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:teri-loxam","name":"Teri Loxam"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Vaxcyte Inc DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-29T06:40:01.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:18","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:harp-dhaliwal","object_label":"Harp Dhaliwal","object_source_name_forms":[],"value":"Harp Dhaliwal: Chief Technical Operations Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:harp-dhaliwal","name":"Harp Dhaliwal"},"title":"Chief Technical Operations Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:1464f89061053a45763a46d1f6ed741f4704d833be9c658fc7c08b99db5a5b56","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PCVX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-06T12:24:23.497224+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:leadership_role:21","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jim-wassil","object_label":"Jim Wassil","object_source_name_forms":[],"value":"Jim Wassil: Executive Vice President and Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jim-wassil","name":"Jim Wassil"},"title":"Executive Vice President and Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-23","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-23","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:ca1aa6cadd13b94924dff4a32ddc105bea93609fa6794b1192f72a5fc3049744","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PCVX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-06T12:24:22.857155+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23T00:00:00+00:00","effective_from":"2026-04-23","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2:committee_record:29","subject_id":"alpha:company:8e53a3b9-9aa2-49f2-8f17-7536d8084ad2","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Annie Drapeau; Members Annie Drapeau (Chair); John Furey","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Annie Drapeau","members":[{"display_name":"Annie Drapeau","person_slug":"annie-drapeau","is_chair":true},{"display_name":"John Furey","person_slug":"john-furey","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:f620658f7d030ad47f35c7637a54b6a5cece62d17a12c8e1c019999b82ca4469","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Vaxcyte Inc DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23","retrieved_at":"2026-04-29T06:40:01.903+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1464f89061053a45763a46d1f6ed741f4704d833be9c658fc7c08b99db5a5b56","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PCVX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-06T12:24:23.497224+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ca1aa6cadd13b94924dff4a32ddc105bea93609fa6794b1192f72a5fc3049744","identity_scope":"source_document_reference","source_type":"sec_filing","title":"PCVX DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":"2026-04-23T00:00:00+00:00","retrieved_at":"2026-05-06T12:24:22.857155+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:9d621d03cbbcba43cef90fa582a64e553294b476f4d74f695aecba11c851c1bc","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1649094/000119312526173672/d64525ddef14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.806,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.747,"cross_source_agreement":0.75,"temporal_completeness":0.385},"diagnostics":{"published_claims":34,"factual_claims":34,"claims_with_linked_evidence":34,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":26,"temporal_claims_with_valid_from":10,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:45:33.016234+00:00","observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":"2026-10-17T04:45:33.016234+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":34,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/vaxcyte-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/vaxcyte-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}